FI973356A - Angiogeneesin inhibitio käyttämällä interleukiini-12:ta - Google Patents

Angiogeneesin inhibitio käyttämällä interleukiini-12:ta Download PDF

Info

Publication number
FI973356A
FI973356A FI973356A FI973356A FI973356A FI 973356 A FI973356 A FI 973356A FI 973356 A FI973356 A FI 973356A FI 973356 A FI973356 A FI 973356A FI 973356 A FI973356 A FI 973356A
Authority
FI
Finland
Prior art keywords
angiogenesis
interleukin
inhibition
Prior art date
Application number
FI973356A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI973356A0 (fi
Inventor
Moses Judah Folkman
Gary Arthur Truitt
Emile Eugene Voest
Original Assignee
Hoffmann La Roche
Childrens Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche, Childrens Medical Center filed Critical Hoffmann La Roche
Publication of FI973356A publication Critical patent/FI973356A/fi
Publication of FI973356A0 publication Critical patent/FI973356A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/208—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI973356A 1995-02-16 1997-08-15 Angiogeneesin inhibitio käyttämällä interleukiini-12:ta FI973356A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38938295A 1995-02-16 1995-02-16
PCT/EP1996/000507 WO1996025171A1 (fr) 1995-02-16 1996-02-07 Inhibition de l'angiogenese a l'aide de l'interleukine-12

Publications (2)

Publication Number Publication Date
FI973356A true FI973356A (fi) 1997-08-15
FI973356A0 FI973356A0 (fi) 1997-08-15

Family

ID=23538033

Family Applications (1)

Application Number Title Priority Date Filing Date
FI973356A FI973356A0 (fi) 1995-02-16 1997-08-15 Angiogeneesin inhibitio käyttämällä interleukiini-12:ta

Country Status (8)

Country Link
EP (1) EP0809511A1 (fr)
JP (1) JPH11500119A (fr)
AU (1) AU4788396A (fr)
BR (1) BR9607427A (fr)
CA (1) CA2212370A1 (fr)
FI (1) FI973356A0 (fr)
TR (1) TR199700801T1 (fr)
WO (1) WO1996025171A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0878200B1 (fr) * 1996-11-22 2003-05-21 Toray Industries, Inc. Agent therapeutique pour maladies ophtalmiques
US6670337B1 (en) 1998-01-29 2003-12-30 Yeda Reaearch And Development Co., Ltd. Facilitation of wound healing with CM101/GBS toxin
US6028060A (en) * 1997-01-29 2000-02-22 Vanderbilt University Treatment of chronic inflammatory diseases with CM101/GBS toxin
US5981508A (en) 1997-01-29 1999-11-09 Vanderbilt University Facilitation of repair of neural injury with CM101/GBS toxin
US5858991A (en) * 1997-01-29 1999-01-12 Vanderbilt University Facilitation of wound healing with CM101/GBS toxin
US6660258B1 (en) 1997-05-09 2003-12-09 Pharma Pacific Pty Ltd Oromucosal cytokine compositions and uses thereof
WO1998053835A1 (fr) * 1997-05-27 1998-12-03 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Utilisation d'oxydes d'azote ou de promedicament a base de ces oxydes pour la prevention et le traitement therapeutique du cancer
WO1999022760A1 (fr) * 1997-11-03 1999-05-14 The Wistar Institute Of Anatomy And Biology Methode et compositions d'inhibition de l'angiogenese et de traitement du cancer
WO2002079157A1 (fr) 2001-03-29 2002-10-10 Schering Corporation Aryloxime-piperazines utiles comme antagonistes de ccr5
WO2004060373A1 (fr) * 2002-12-27 2004-07-22 Santen Pharmaceutical Co., Ltd. Agent therapeutique pour la degenerescence maculaire humide liee a l'age
CA2518823A1 (fr) 2003-03-24 2004-10-07 F.Hoffmann-La Roche Ag Benzyl-pyridazinones en tant qu'inhibiteurs de transcriptase inverse
BRPI0617720A2 (pt) 2005-10-19 2011-08-02 Hoffmann La Roche compostos inibidores de nnrt de fenil-acetamida, usos dos referidos compostos e composição farmacêutica que os contém
RU2451676C2 (ru) 2006-08-16 2012-05-27 Ф.Хоффманн-Ля Рош Аг Ненуклеозидные ингибиторы обратной транскриптазы
RU2469032C2 (ru) 2006-12-13 2012-12-10 Ф.Хоффманн-Ля Рош Аг Производные 2-(пиперидин-4-ил)-4-фенокси- или фениламинопиримидина в качестве ненуклеозидных ингибиторов обратной транскриптазы
CA3031083A1 (fr) * 2016-07-18 2018-01-25 Neumedicines Inc. Utilisations de il-12 comme agent immunotherapeutique de remplacement

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2106368A1 (fr) * 1992-01-16 1993-07-17 Theodore E. Maione Methodes et compositions pour le traitement de la maladie angiogenique
JPH06157344A (ja) * 1992-02-07 1994-06-03 Childrens Medical Center Corp:The 血管新生阻害のための医薬製剤及び血管新生阻害方法

Also Published As

Publication number Publication date
WO1996025171A1 (fr) 1996-08-22
TR199700801T1 (xx) 1998-03-21
MX9706188A (es) 1997-11-29
AU4788396A (en) 1996-09-04
CA2212370A1 (fr) 1996-08-22
JPH11500119A (ja) 1999-01-06
EP0809511A1 (fr) 1997-12-03
BR9607427A (pt) 1998-06-23
FI973356A0 (fi) 1997-08-15

Similar Documents

Publication Publication Date Title
FI932599A (fi) Foerfarande foer modifiering av ytorna av foerformade substrat genom ymppolymerisation
FI955093A0 (fi) Datornaetelettelefonsystem och foerfarande foer styrning av det
DE69625622D1 (de) Angiogenese Inhibitoren
FI931487A0 (fi) Foerfarande foer framstaellning av myrsyra genom termisk soenderdelning avkvaternaera ammoniumformiat
NO974423L (no) Tolkning av formasjonsgrenseflater
FI973356A (fi) Angiogeneesin inhibitio käyttämällä interleukiini-12:ta
FI945397A0 (fi) Foerbaettrad syrsaettning av talloljetvaol genom anvaendning av koldioxid
FI100905B (fi) Seinäelementti
NO990832D0 (no) Syntese av bisendolylmalimider
NO980862D0 (no) Zwitterinoformer av trovafloxacin
NO980501D0 (no) Fôring av rör
FI2181U1 (fi) Aemne foer framstaellning av en lim- och limbalksskiva
IS4339A (is) Hömlun ljóssundurliðunar á 3-setnum-2-oxindólum
FI950686A0 (fi) Anordning foer oeverfoering av spillvaermo till jordenergipumpeno jordkrets
FI950265A (fi) Elementtirakenteinen seinä
FI925109A0 (fi) Anordning foer drivning av klenvirke genom massbehandlingsfoerfarande
FI952808A0 (fi) Rensapparat foer invaendig rengoering av luftkanaler med rektangulaert tvaersmitt
FIU950441U0 (fi) Glasfoeremaol med bihang av metalltraod
FI955924A0 (fi) Rengoering av skivvaermevaexlare med effektultraljud
FI951070A0 (fi) Regleranordning av spolvatten foer WC-stol
FI951523A0 (fi) Foerfarande foer utfoerande av neuralalkyl genom att anvaenda sjaelvorganiserande karta och foerfarandets tilllaempningar
FI1800U1 (fi) Anordning foer koppling av tvao svaengbara ramar till varandra
FI954568A0 (fi) Foerfarande foer byggande av yttervaeggar till smaohus
FI953253A0 (fi) Vaermeackumulerande element av bastugn
FI954335A0 (fi) Modulaert isolerelement foer montering av avlopps- och ventilationsroer